Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@aleabitoreddit

Serenity on X

Counterpoint on $MRVL / $LITE acqusition: - "Every buyer that competes with Marvell will want a second, independent laser source". They identify $SIVE / Scintil Photonics as new CW / ELS capacity, with names like $CRDO as potential partners of Sivers. - "With Lumentum sold out for years, the overflow goes to whoever has merchant capacity" Already said this before, but we'll likely see some incentive to diversify laser sourcing. Sivers was cited here, and comes online with 100M lasers / external foundry capacity (2:1 external/internal target). To demonstrate the sheer scale on that, $AAOI exit 2026 laser capacity target was roughly ~24M/year (but different blend). - "Module makers move upstream" was also another second order effect. $JBL as one example is now heavily competing with the combined Lumentum + Marvell.... There's other players like $SMTC that are explicitly doing M&A for expanding laser capacity. I don't think the overall AI valuation crash is representative of individual company strength in the optical sector. There's very compelling opportunities in the laser bottleneck in the upcoming year that I believe markets are mispricing.
@aleabitoreddit

Serenity on X

Just to show a point... AI names have crashed so much to the point $POET as a business is now considered close to worthless. It's now $829.7M MC vs. ~$788M net cash. And below its $847.5M book value. Considering institutions were funding it $400m at $21, with $26.25 exercisable warrants few months ago and it's back to ~$4.8. Poet would need to rally +337.5% just to return back to the original financing price. "FOGO" (Fear of Getting Obliterated) have hit extreme levels if "growth" companies are priced near liquidation values.

Investor Letters

All letters

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 5 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 4 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.